Library

Signorelli M, Ayoglu B, Johansson C, et al. Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker…

Spitali P, Zaharieva I, Bohringer S, et al. TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy.…

Abrams T, Adkins B. Tragic Affirmation: Disability Beyond Optimism and Pessimism. J Med Humanit 2020   Abstract Tragedy is a…

Lennie JL, Mondick JT, Gastonguay MR. Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A…

Fox H, Millington L, Mahabeer I, van Ruiten H. Duchenne muscular dystrophy. BMJ (Clinical research ed.) 2020;368:l7012-l7012   Commentary by Frank…

Takeuchi F, Nakamura H, Yonemoto N, et al. Clinical practice with steroid therapy for Duchenne muscular dystrophy: An expert survey…

James KA, Gralla J, Ridall LA, et al. Left ventricular dysfunction in Duchenne muscular dystrophy. Cardiol Young 2020;30:171-176   Abstract…

Hellebrekers DMJ, Doorenweerd N, Sweere DJJ, et al. Longitudinal follow-up of verbal span and processing speed in Duchenne muscular dystrophy.…

Komaki H, Maegaki Y, Matsumura T, et al. Early phase 2 trial of TAS-205 in patients with Duchenne muscular dystrophy.…

Naarding KJ, Reyngoudt H, van Zwet EW, et al. MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne…